Literature DB >> 8705787

Radioimmunological and immunohistochemical study of carcinoembryonic antigen in pleomorphic adenoma and mucoepidermoid carcinoma of the salivary glands.

A Angelov1, A Klissarova, K Dikranian.   

Abstract

The aim of the present study was the evaluation of CEA-radio-immunoassay and CEA-immunohistochemistry in the management of pleomorphic adenoma and mucoepidermoid carcinoma of salivary glands. 23 pleomorphic adenomas, 9 mucoepidermoid carcinomas, and 7 normal salivary glands were examined. CEA-concentration in serum and saliva were assayed before and after surgery. Polyclonal CEA antibody was used for immunohistochemical CEA detection in the tumor tissue and in the normal salivary glands. The mean CEA concentrations were found to be 14.94 ng/ml in the serum and 216.67 ng/ml in the saliva of patients with mucoepidermoid carcinoma. These values were considerably higher compared to healthy controls (188.64 ng/ml in saliva) and in patients with pleomorphic adenoma - 7.65 ng/ml in serum and 189.35 ng/ml in saliva (P < 0.001). A correlation was found between high CEA concentration in the saliva and the intensity of CEA expression in the tumour tissue. An increased synthesis and secretion of CEA was determined by the prevalence of tubular structures, a high proliferative activity in pleomorphic adenoma, and its malignant transformation.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8705787

Source DB:  PubMed          Journal:  Gen Diagn Pathol        ISSN: 0947-823X


  3 in total

1.  A joint detection of CEA and CA-50 levels in saliva and serum of patients with tumors in oral region and salivary gland.

Authors:  Hong He; Guanfu Chen; Liang Zhou; Yanmin Liu
Journal:  J Cancer Res Clin Oncol       Date:  2009-03-26       Impact factor: 4.553

2.  Ultrasensitive Point-of-Care Test for Tumor Marker in Human Saliva Based on Luminescence-Amplification Strategy of Lanthanide Nanoprobes.

Authors:  Shanyong Zhou; Datao Tu; Yan Liu; Wenwu You; Yunqin Zhang; Wei Zheng; Xueyuan Chen
Journal:  Adv Sci (Weinh)       Date:  2021-01-06       Impact factor: 16.806

3.  Human prominin-1 (CD133) is detected in both neoplastic and non-neoplastic salivary gland diseases and released into saliva in a ubiquitinated form.

Authors:  Jana Karbanová; Jan Laco; Anne-Marie Marzesco; Peggy Janich; Magda Voborníková; Jaroslav Mokrý; Christine A Fargeas; Wieland B Huttner; Denis Corbeil
Journal:  PLoS One       Date:  2014-06-09       Impact factor: 3.240

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.